(Q42949202)

English

Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study

scientific article published on July 1, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

neuropathic pain

0 references

0 references

author name string

Concepción Pérez

1

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Ana Navarro

2

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Xavier Masramón

4

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Javier Rejas

5

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

María T. Saldaña

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20678683

15 June 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20678683

15 June 2024

publication date

1 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0149291810002419?httpAccept=text/xml

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

https://api.elsevier.com/content/article/PII:S0149291810002419?httpAccept=text/plain

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

1357-1370

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Neuropathic pain: redefinition and a grading system for clinical and research purposes

1

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Neuropathic pain: a practical guide for the clinician

2

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Clinical characteristics and economic costs of patients with painful neuropathic disorders

3

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Painful neuropathic disorders: an analysis of the Régie de l'Assurance Maladie du Québec database

4

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Depression and anxiety associated with three pain conditions: results from a nationally representative sample.

5

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep.

6

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach

7

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Managing pain and comorbid depression: A public health challenge

8

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature

9

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

10

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community.

11

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions.

12

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

The burden of neuropathic pain: results from a cross-sectional survey.

13

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

14

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy.

15

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

A registry of the aetiology and costs of neuropathic pain in pain clinics : results of the registry of aetiologies and costs (REC) in neuropathic pain disorders study

16

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Neuropathic pain: the global challenge

17

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Unmet Needs in the Management of Neuropathic Pain

18

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

EFNS guidelines on pharmacological treatment of neuropathic pain.

19

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

20

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Algorithm for neuropathic pain treatment: an evidence based proposal.

21

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions

22

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?

23

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin

24

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings

25

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

26

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.

28

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia

29

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia

30

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings

31

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings

32

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

33

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component

34

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

The short-form McGill Pain Questionnaire

35

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

The hospital anxiety and depression scale

36

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

EuroQol--a new facility for the measurement of health-related quality of life

37

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

The measurement of disability.

38

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Development and validation of the Neuropathic Pain Symptom Inventory

40

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain.

41

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Work-related disability: results from the American migraine study.

42

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Work-related disability: results from the American migraine study.

43

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

EuroQol: the current state of play

46

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

From the Bench to the Trench: A Comparison of Sertraline Treatment of Major Depression in Clinical and Research Patient Samples

47

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.

48

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

49

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia

50

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings

51

1 reference

10.1016/J.CLINTHERA.2010.07.014

https://api.crossref.org/works/10.1016/J.CLINTHERA.2010.07.014

15 June 2024

Identifiers

10.1016/J.CLINTHERA.2010.07.014

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42949202&oldid=2180032952"